Kliniken & Institute ... Kliniken Chirurgische Klinik... General, Visceral and... Research Pankreasforschung Sektion... Molecular OncoSurgery ... Talks and Congresses ...

2018

January: 38. Jahrestagung des Deutschen Pankreasclubs e.V., Ulm. Speech I. Herr: Intraductal papillary mucinous neoplasm of the pancreas rapidly xenografts in chicken eggs and predicts aggressiveness;

Poster presentation S. Karakhanova: Immunoregulatory effects of sulforaphane in pancreatic cancer

 

2017

September: Congress 5. Symposium DGPE, University Gießen. Speech I. Herr: Brokkoli und Co. - Krebsprävention durch Ernährung

 

May: Maimarkt, Mannheim. Speech I. Herr: Brokkoli und Co. - Krebsprävention durch Ernährung

 

March: Grüne Damen, Stuttgart. Speech I. Herr: Brokkoli und Co. Natürliche Krebsfeinde

 

March: Society for Biological Cancer Fighting, Education Seminar for Therapists: Integrative Biologische Krebsmedizin, Heidelberg. Speech I. Herr: Sekundäre Pflanzenstoffe: Experimentelle und klinische Studienergebnisse unter besonderer Berücksichtigung der Kreuzblütlerpflanzen.

2016

December: Aman Group, Dietenheim, Augsburg, Erligheim und Bönnigheim. Vortrag I. Herr: Brokkoli und Co. - Krebsprävention durch Ernährung

 

September: Association prostate cancer self-help  North Rhine-Westphalia e.V., Therapy Seminar for the leader of the prostate self-aid groups, Essen. Speech I. Herr: Brokkoli und Co bei Prostatakarzinom.

 

July: Annual DKFZ PhD Retreat, Weil der Stadt. Speech C. Nwaeburu: Up-regulation of microRNA Let-7c by quercetin inhibits pancreatic cancer progression by activation of Numbi

 

June: International PhD Student Conference, University of Cambridge, UK. Poster C. Nwaeburu: Quercetin-induced microRNA inhibits tumor progression in vivo in chick egg xenograft model

 

April: Interdisziplinary Lecture Series of the University of Heidelberg, Heidelberg. Speech: I. Herr: Brokkoli und Co. Der Einfluss der Ernährung auf Krebs.

 

April: Society for Biological Cancer Fighting, Education Seminar for therapists: Integrative Biologische Krebsmedizin, Heidelberg. Speech I. Herr: Sekundäre Pflanzenstoffe: Experimentelle und klinische Studienergebnisse unter besonderer Berücksichtigung der Kreuzblütlerpflanzen.

April: Federal Institute for Risk Evaluation, Information Event of the Study Foundation of the German Nationals, Berlin. Speech I. Herr: Brokkoli und Co: Ernährung und Krebs.

 

 

 

2015

November: DKFZ Poster Presentation of PhD students, Heidelberg.
Poster presentation A. Abukiwan: Dexamethasone-induced microRNA regulation for pancreatic cancer progression.

November: Information day for patients, Breast Center GRN-Klinik, Weinheim.
Speech I.Herr: Brokkoli und Co. Krebsprävention durch Ernährung.

October: 6. Education seminar of the  ecumenical nurses of the University clinic Heidelberg, Walpiratencamp, Heidelberg.
Speech I. Herr: Krebsprävention durch Ernährung, Brokkoli und Co.

October: 3rd European Platform Summer School in Translational Cancer Research, Albufeira, Portugal.
Speech C. Nwaeburu: Quercetin-induced miRNA-X switches the mode of Cancer Stem Cells (CSCs) division and inhibits CSCs-like features in pancreatic cancer.

September: Horizons Symposium, Göttingen.

Speech C. Nwaeburu: Quercetin-induced miRNA-X switches the mode of Cancer Stem Cells (CSCs) division and inhibits CSCs-like features in pancreatic cancer.


Juli: DKFZ PhD Retreat, Weil der Stadt.
Speech N. Bauer: Personalized models of pancreatic cancer on chick eggs.

Juni: DKFZ Poster Presentation of PhD-Students, Heidelberg. 
Poster presentation N. Bauer: Personalized models of pancreatic cancer on chick eggs.

März:Medicine in the evening, Medical Faculty Heidelberg.

Speech I. Herr: Brokkoli und Co. Krebsprävention durch Ernährung.

 

March: Basic Course Integrative Biological Cancer Medicine (IBKM), education event of the Society for Biological Cancer Defence, Heidelberg.

Speech I. Herr: Brokkoli und Co. Krebsprävention durch Ernährung.

 

February: Sozietät Czerny, Medical Faculty Heidelberg.

Speech I. Herr: Brokkoli und Co. Krebsprävention durch Ernährung.

 

 

2014

November 2014: European Pancreas Center, weekly seminar, Heidelberg. 

Speech I. Herr: From new therapeutic treatment options and chick eggs in pancreatic cancer.

 

Oktober: Status seminar 2014, Alternative methods for animal experiments, Berlin.

Speech I. Herr, N. Bauer: Bruteier zur Definition von Tumorstammzell-Markern und für personalisierte Therapiestudien.

 

Oktober: 19th World Congress on Advances in Oncology and 17th International Symposium on Molecular Medicine. Athens, Greece.

Speech I. Herr: New treatment options for pancreatic cancer.

Speech L. Liu: Triptolide reverses hypoxia-induced epithelial-mesenchymal transition and stem-like features in pancreatic cancer by NF-kB downregulation.

Speech N. Bauer: Induction of hypoxia in a mammalian replacement model for intervention therapy in pancreatic cancer in vivo. 

 

 

Juli: Series of Lectures of the Interfaculty Biomedical Research Facility  (IBF) of the University of Heidelberg, Heidelberg, Germany.

Speech I. Herr: Possibilities and limits of  tumor-xenotransplantation on fertilized chicken eggs.

 

 

Juli: Series of Lectures in Reduction, Refinement, Replacement (3R), Possibilities of implementation in biomedical research. Central animal laboratory of the German Cancer Research Center (DKFZ), Heidelberg, Heidelberg, Germany. 

Speech I. Herr: Possibilities and limits of  tumor-xenotransplantation on fertilized chick eggs.

March: Basic Course Integrative Biological Cancer Medicine (IBKM), education event of the Society for Biological Cancer Defence, Heidelberg, Germany. 

Speech I. Herr: Cancer, Nutrition and Physical Activity. 

 

 

 

 

January: Congress of the German Pancreasclub (DPC), Mannheim, Germany. 

Speech F. Schönsiegel: Genomic and non-genomic effects of glucocorticoids enhance aggressivity of pancreatic cancer by inducing EMT- and stemness. 

Speech L. Liu: Triptolide reverses hypoxia-induced epithelial–mesenchymal transition and stem-like features in pancreatic cancer by NF-κB downregulation

Poster A. Kaczorowski: Elimination of pancreatic CSC by MSC delivered oncolytic adenoviruses

Poster Y. Zhang: Synergistic activity of aspirin and gemcitabine abolishes pancreatic cancer stem cell characteristics through inhibition of NF-κB signaling

2013

December: Sozietät Czerny, Medizinische Fakultät Heidelberg, Heidelberg.  Vortrag I. Herr: Ernährung, Bewegung und Krebs.

November: American Institute for Cancer Research, Annual Research Conference on Food, Nutrition, Physical Activity and Cancer, 2013. Bethesda, Maryland, USA. 

 

October: German-Israeli Foundation Project Meeting, Heidelberg 2013. Heidelberg. Talk I. Herr: Glucocorticoids enhance aggressivity of pancreatic cancer by inducing EMT- and stemness.

 

June: Pancreatic Cancer Meeting, Salerno 2013. Salerno, Italy. Talk I. Herr: The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem-cell signaling in pancreatic cancer.

 

May: Invitation Ärztehaus Hirsch Apotheke to a lecture evening , Ulm, Germany. Talk I. Herr: Ernährung, Bewegung und Krebs.

 

May: Invitation to the 16th International congress of the society for biological cancer defence e.V., Print Media Academy, Heidelberg, Germany. Talk I. Herr: Secondary plant substances: Experimental and clinical study results with focus to cruciferous vegetables. 

 

 

April: Pancreatic Cancer Research Meeting, International Science Forum, Heidelberg, Germany. Talk I. Herr: Therapeutic options for elimination of pancreatic cancer stem cells. 

 

 

April: Sozietät Czerny, Universitätsklinikum Heidelberg, Germany. Talk I. Herr: Foods, Nutrition, Physical Activity and Cancer. 

 

March: Invitation of the society for biological cancer defence to the basic course"Integrative Biological Cancer Medicine", NH-Hotel, Heidelberg, Germany. Talk I. Herr: Secondary plant substances: Experimental and clinical study results with focus to cruciferous vegetables. 

 

2012

Dez: Sozietät Czerny, Universitätsklinikum Heidelberg, Germany.

Talk I. Herr: Food, Nutrition, Physical Activity and Cancer. 

 

Nov: Invitation of the Cold Spring Harbor Asia Conferences Tumor Microenvironment, Suzhou, China

Talk I. Herr: Selection of established and primary models of pancreatic cancer stem cells and therapeutic targeting.

 

Jun: Award of the Sebastian-Kneipp-Preises, Bad Wörishofen, Germany

Talk I. Herr: Food, Nutrition, Physical Activity and Cancer. 

 

Mai: Inaugural Lecture, Medical Faculty  Heidelberg, Gemany 

Talk I. Herr: Food, Nutrition, Physical Activity and Cancer. 

 

Jan: Invitation from the LMMCC. Luxemburg, Luxemburg 

Talk I. Herr: Targeting of pancreatic cancer stem cells by bioactive agents from nutrition and marine sponges.

 

 

2011

Nov:   AICR Conference on Food, Nutrition, Physical Activity and Cancer. Washington, USA. 

Poster I. Herr: Involvement of autophagy in survival of pancreatic tumorigenic cells in oxygen- and nutrition-depleted environments.


Nov:   16th World Congress on Advances in Oncology. Rhodos, Greece

Presentation I.Herr: Identification and targeting of tumor-initiating cells in pancreatic cancer. 


Oct:   Arzt-Patienten-Tag an der Chirurgischen Universitätsklinik. Heidelberg, Germany. 

Presentation I.Herr: Nahrungsmittel, Ernährung, körperliche Bewegung und Krebs. 

 

Sep:   Deutscher Fachausschuss für Arznei-, Gewürz- und Aromapflanzen (DFA), Berlin, Germany. 

Presentation I. Herr: Glucosinolate aus der Familie der Kreuzblütler bei der Prävention und Therapie von Krebs.

 

Mar:   Frontier-Symposium, University of Heidelberg, Heidelberg, Germany

Presentation I. Herr: Knochenmarkszellen aus Schwein zur Behandlung menschlicher Leberschäden?

 

2010

Nov: Perspectives for Translational Medicine in Heidelberg, Heidelberg, Germany

Presentation I. Herr: Diverse functions of adult stem cells in gastrointestinal cancer

 

Nov: EORTC-NCI-AACR Kongress 2010, Berlin, Germany

Poster I. Herr: Sulforaphane enhances effects of sorafenib, quercetin, and chemotherapy toward pancreatic cancer stem-like cells.

 

Nov: EEBC 2010, Exercise, Energy Balance and Cancer, Heidelberg, Germany

Poster I. Herr: Autophagy may enable survival of pancreatic cancer stem cells in oxygen- and nutrition depleted tumor microenvironments

 

Nov: APA 2010, Annual Research Conference of the American Pancreatic Association, Chicago, USA
Poster I. Herr: Marine sponge Crambe crambe for efficient elimination of pancreatic cancer stem cells

 

Oct: AICR 2010, Annual Research Conference of the American Insititute of Cancer Research: Food, Nutrition, Physical Activity and Cancer, Washington D.C., USA

Poster I. Herr: Autophagy enables survival of pancreatic cancer stem cells in oxygen- and nutrition depleted tumor microenvironments

 

Oct: 15 th World Congress on Advances in Oncology and 13 th International Symposium on Molecular Medicine, Loutraki, Greece

Presentation A. Salnikov

 

Oct: 6th Swiss Apoptosis Meeting, 2010, Bern, Switzerland

Poster S.Labsch: Sulforaphane potentiates gemcitabine mediated cytotoxicity towards cancer stem cells

 

Jul: 14 th International Congress of Immunology, Kobe, Japan

Presentation & Poster A. Salnikov: Overexpression of TRAIL in lymphocytes enhances bispecific EpCAMxCD3 antibody immunotherapy against pancreatic tumor initiating cells.

 

Feb: Deutscher Krebskongress, Berlin, Germany
 Vortrag I. Herr: Targeting of pancreatic cancer stem cells by sorafenib and broccoli-derived dietary ingredient sulforaphane

 

 

2009

Nov: Deutscher Pankreasclub, Heidelberg.
Presentation A. Salnikov: Enhanced gene therapy with trail by specific antibody immuno therapy in advanced pancreatic cancer 

 

 

Nov: APA - Annual Meeting, Honolulu, Hawaii, USA.
Poster I. Herr: Targeting of pancreatic cancer stem cells by chemopreventive agents

 

 

Nov: China Biomedical Innovations Conference 2009, Shanghai, China,
Presentation A. Salnikov
: Targeting of pancreatic carcinoma and CSCs by bispecific EpCAMxCD3  antibody.

 

 

Sep: Gordon Research Conference: Stem Cells and Cancer, Les Diablerets, Switzerland,
Poster A. Salnikov: Targeting of cancer stem cell marker EpCAM by bispecific antibody EpCAMxCD3 inhibits pancreatic carcinoma.

 

 

Mai: Mesenchymal Stromal Cells and Tumor Microenvironment: an update, Montpellier; France  
Poster I. Herr: Influence of inflammation to the liver regenerative potential of MSCs in transplantation

 

 

2008

Nov: Annual Meeting of the American Pancreatic Association, Special Symposium: The Continuum from Chronic Pancreatitis to Pancreatic Cancer. Chicago, IL, USA.

Poster I. Herr: Sulforaphane eradicates pancreatic cancer stem cells by NF-KB.

 

Oct: 8th International Conference of Anticancer Research, Kos, Greece.

Presentation I. Herr:

 

Oct: 2nd International Symposium on EpCAM and Cancer Stem Cell Markers, Tutzing, Munich, Germany

Presentation A. Salnikov: Targeting of pancreatic carcinoma and CSCs by bispecific EpCAMxCD3 antibody.

 

Oct: 5th Heinrich F.C. Behr Symposium,“Stem Cells and Cancer,” DKFZ, Heidelberg, Poster Presentation

Poster G.,Kallifatidis: Profiling and targeting of cancer stem cells.

 

Sep: The Joint Annual Meeting of Immunology of the Austrian and German Societies, Vienna, Austria

Poster A. Salnikov: Bispecific EpCAMxCD3 antibody eradicates tumors in vivo and potently stimulates lymphocytes in 3D tumor recpmstrict syste, om vitro.

 

Mai: Onkologischer Arbeitskreis Heidelberg, Heidelberg

Presentation I. Herr: Evaluation of human mesenchymal stem cells for anti-angiogenic therapy of pancreatic cancer

 

Feb: American Association for Cancer Research, AACR, Conference 'The Role of Cancer Stem Cells in the Initiation and Propagation of Tumorigenesis, Los Angeles, CA, USA

Participation : A. Salnikov
Poster A. Salnikov: Migratory properties of CD133+ cancer stem cells from Huh 7 hepatocelllular carcinoma cell line
Poster G. Kallifatidis: Sulforaphane eradicates pancreatic cancer stem cells by NF-KB.

 

2007

Nov: Symposium "Pancreatic Cancer 2007: Stem Cells in Pancreas and Pancreatic Cancer", The American Pancreatic Association / Lustgarten Foundation, Chicago, IL, USA
Participation I. Herr

 

Oct: 11.Onkologischer Alpengipfel, Loas, Österreich

Presentation I.Herr: Krebsstammzellen in soliden Tumoren

 

Jul: 39. Meeting of the European Pancreatic Club, Newcastle Gatheshead, UK

Award for best basic science paper

Presentation P.Büchler: Bone marrow derived MSC for Therapy od pancreatic carcinoma

 

Jun: 18. Workshop für experimentelle und klinische Lebertransplantation und Hepatologie, Wilsede, Germany

Presentation B. Beckermann:  Bone marrow derived mesenchimal stem cells for therapeutic intervention in liver disease

Poster A. Groth: On the TRAIL to therapeutic intervention in liver disease

Poster V. Rausch: Glucocorticoid-induced therapy resistance in solid tumors – a role for recurrence od HCC in liver transplantation

 

Jun: Einladung von Prof. Holger Kalthoff zum Seminar SFB 415 "Specificity and Pathophysiology of Signal Transduction Pathways", Kiel

Presentation I. Herr

 

Apr: 14. Forschungskolloquium des Tumorzentrums Heidelberg/Mannheim, Heidelberg

Vortrag I. Herr: Evaluation humaner mesenchimaler Stammzellen zur antiangiogenen Therapie des Pankreaskarzinoms

 

Mar: Fourth International  Conference on Tumor Microenvironment: Progression, Therapy and Prevention,Florence, Italy

Teilnahme : I. Herr

 

2006

Dec: Seminar Molecular Mechanisms in Health and Disease, DKFZ, Heidelberg

Vortrag G. Kallifatidis: Adenomatous Polyposis coli determines Sensivity to Histamine Deacetylase Inhibitor-induced Apoptosis

 

Dec: DKFZ PhD Poster Session, DKFZ, Heidelberg

Poster Presentation G. Kallifatidis: Mesenchymal Stem Cells and TRAIL-induced Apoptosis in Prostate and Pancreatic Carcinomas

 

Dec: Universität Göttingen, Medizinische Fakultät, Göttingen

Presentation I. Herr: Krebsstammzellen bei soliden Tumoren

 

Nov: Ernst Schering Foundation, Berlin
WORKSHOP ON CANCER STEM CELLS: NOVEL CONCEPTS AND PROSPECTS FOR TUMOR THERAPY

Participation: G. Kallifatidis, B. Beckermann, I. Herr

 

Nov: Universitäts Kinderklinik, Heidelberg

Presentation I. Herr: Molecular Strategies in Oncology

 

Oct: 11th World Congress on Advances in Oncology and 9th International Symposium on Molecular Medicine, Crete, Greece.

Presentation I. Herr: Molecular Strategies in Oncology

 

Sep: Kongress der Deutschen Gesellschaft für Urologie 2006, CCH, Hamburg

Poster B. Beckermann: Mesenchimal Stem Cells and Angiogenesis in Prostate Cancer

 

Sep: XI. DKFZ PhD Retreat, Weil der Stadt

Poster G. Kallifatidis: Mesenchymal Stem Cells (MSCS) and TRAIL-induced  Apoptosis in Prostate and Pancreatic Tumours (Poster design and presentation: 1st prize awarded)

 

Mai: DKFZ PhD Retreat, Weil der Stadt

Poster B. Beckermann: Mesenchymal Stem Cells and Angiogenesis in Pancreatic and Prostate Cancer

 

Jun: Istituto Toscano Tumori, Universität Genova, Florence, Italy.

Presentation I. Herr: Molecular Strategies in Obcology with Topic Prostate Carcinoma

 

Mai: Universität Bochum, Pathologisches Institut, Medizinische Fakultät der Universität, Bochum

Presentation I. Herr: Molecular Strategies in Obcology with Topic Prostate Carcinoma

 

Apr: Universität Freiburg, Medizinische Fakultät und Urologische Universitätsklinik, Freiburg

Presentation I. Herr: Molecular Strategies in Obcology with Topic Prostate Carcinoma

 

Mar: Deutscher Krebskongress, Berlin

Presentation I. Herr: Prospective Study of Glucocorticoid Co-medication and Risk od Resistance toward Cancer Therapy in solid Tumor Specimen, Cell Lines and Xenografts

 

Jan: Centre for Translational Oncology, Institute of Cancer and the CR-UK Clinical Centre, Barts and the London Queen Mary´s School of Medicine and Dentistry, London, UK.

Presentation I. Herr: Therapy resistance od Tumors and Therapeutic Stategies

 

Mar: Heinrich F. C. Behr Symposium „Stem Cells and Cancer“, DKFZ, Heidelberg

Poster: G. Kallifatidis: Mesenchymal Stem Cells and TRAIL-induced Apoptosis in prostate Tumors
Presentation and Poster : B. Beckermann: Mesenchymal Stem Cells and Angiogenesis in pancreatic and prostate Cancer